Physician profile
Glenn E Taylor
NPI 1689675878
$1,399.20
in general payments reported to CMS, 2019-2025
20 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $301 · 2021: $51.49 · 2022: $87.96 · 2023: $191 · 2024: $233 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $267.16 | 2019-2022 | |
| Novo Nordisk INC | $237.51 | 2019-2025 | Wegovy |
| Amgen INC. | $199.96 | 2019-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $148.54 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $91.22 | 2019-2024 | Airsupra, Farxiga |
| Teva Pharmaceuticals USA, INC. | $67.04 | 2019-2020 | |
| Glaxosmithkline, LLC. | $52.24 | 2019-2024 | Trelegy Ellipta |
| Abbvie INC. | $51.57 | 2023-2024 | Vraylar |
| Merck Sharp & Dohme LLC | $46.28 | 2019-2020 | |
| Abbott Laboratories | $40.93 | 2023-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $27.47 | 2019-2020 | |
| Hologic Sales and Service, LLC | $24.62 | 2025 | Aptima, Thinprep 2000 Processor |
| Olympus America INC. | $23.74 | 2025 | Itind System |
| Astellas Pharma US INC | $22.35 | 2023 | Veozah |
| Sanofi Pasteur INC. | $19.81 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $19.01 | 2019 | |
| Amarin Pharma, INC. | $18.01 | 2020 | |
| Cranial Technologies, INC | $16.33 | 2025 | Doc Band |
| Novartis Pharmaceuticals Corporation | $15.02 | 2019 | |
| Dynavax Technologies Corporation | $10.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.